1. Home
  2. KRO vs REPL Comparison

KRO vs REPL Comparison

Compare KRO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$6.38

Market Cap

730.6M

Sector

Industrials

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.19

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRO
REPL
Founded
1916
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
730.6M
692.8M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
KRO
REPL
Price
$6.38
$7.19
Analyst Decision
Strong Sell
Buy
Analyst Count
2
9
Target Price
$6.00
$11.13
AVG Volume (30 Days)
379.1K
1.3M
Earning Date
03-09-2026
02-03-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
5.25
EPS
N/A
N/A
Revenue
$1,859,400,000.00
N/A
Revenue This Year
$3.47
N/A
Revenue Next Year
$11.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$2.68
52 Week High
$7.90
$13.24

Technical Indicators

Market Signals
Indicator
KRO
REPL
Relative Strength Index (RSI) 63.28 46.67
Support Level $5.89 $6.81
Resistance Level $6.74 $8.82
Average True Range (ATR) 0.33 0.49
MACD 0.14 0.02
Stochastic Oscillator 88.28 31.47

Price Performance

Historical Comparison
KRO
REPL

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: